Patents by Inventor Elliot K. Chartash

Elliot K. Chartash has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of TNFAlpha Inhibitor for Treatment of Psoriasis
    Publication number: 20150071938
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Application
    Filed: October 9, 2014
    Publication date: March 12, 2015
    Inventors: Rebecca S. Hoffman, Mark Weinberg, Lori K. Taylor, Elliot K. Chartash, Philip Yan, George R. Granneman
  • Uses and Compositions for Treatment of Psoriasis
    Publication number: 20150050216
    Abstract: The invention provides methods, uses and compositions for the treatment of psoriasis. The invention describes methods and uses for treating psoriasis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to treat psoriasis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment psoriasis in a subject.
    Type: Application
    Filed: July 8, 2014
    Publication date: February 19, 2015
    Inventors: Mary Kaye Willian, Martin M. Okun, Rebecca S. Hoffman, Yihua Gu, Lisa E. Melilli, Kenneth B. Gordon, Subhashis Banerjee, Lori K. Taylor, Daniel E. Tracey, Elliot K. Chartash, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven A. Fischkoff, George R. Granneman
  • Use of TNF-alpha inhibitor for treatment of psoriasis
    Patent number: 8906373
    Abstract: The invention describes methods of treating erosive polyarthritis comprising administering a TNF? antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNF? antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis.
    Type: Grant
    Filed: April 30, 2014
    Date of Patent: December 9, 2014
    Assignee: AbbVie Biotechnology Ltd.
    Inventors: Subhashis Banerjee, Rebecca S. Hoffman, Mark Weinberg, Lori K. Taylor, Clive E. Spiegler, Daniel E. Tracey, Elliot K. Chartash, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven A. Fischkoff, George R. Granneman
  • Multiple-variable dose regimen for treating TNF?-related disorders
    Patent number: 8889136
    Abstract: Multiple-variable dose methods for treating TNF?-related disorders, including Crohn's disease and psoriasis, comprising administering TNF? inhibitors, including TNF? antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF-inhibitor is administered in a higher dosage during the induction phase.
    Type: Grant
    Filed: April 11, 2005
    Date of Patent: November 18, 2014
    Assignee: AbbVie Biotechnology Ltd.
    Inventors: Rebecca S. Hoffman, Elliot K. Chartash, Lori K. Taylor, George R. Granneman, Philip Yan
  • TREATMENT OF TNFALPHA RELATED DISORDERS
    Publication number: 20140286941
    Abstract: Methods of treating TNF?-related disorders comprising administering TNF? inhibitors, including TNF? antibodies are described.
    Type: Application
    Filed: May 2, 2014
    Publication date: September 25, 2014
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel E. Tracey, Elliot K. Chartash, Rebecca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven A. Fischkoff
  • TREATMENT OF TNFALPHA RELATED DISORDERS
    Publication number: 20140286939
    Abstract: Methods of treating TNF?-related disorders comprising administering TNF? inhibitors, including TNF? antibodies are described.
    Type: Application
    Filed: May 2, 2014
    Publication date: September 25, 2014
    Applicant: AbbVie Biotechnology, Ltd.
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel E. Tracey, Elliot K. Chartash, Rebecca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven A. Fischkoff
  • TREATMENT OF TNFALPHA RELATED DISORDERS
    Publication number: 20140286940
    Abstract: Methods of treating TNF?-related disorders comprising administering TNF? inhibitors, including TNF? antibodies are described.
    Type: Application
    Filed: May 2, 2014
    Publication date: September 25, 2014
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel E. Tracey, Elliot K. Chartash, Rebecca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven A. Fischkoff
  • METHODS FOR TREATING PSORIASIS
    Publication number: 20140079714
    Abstract: The invention provides methods of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: September 11, 2013
    Publication date: March 20, 2014
    Inventors: Joaquin Mario Valdes, Elliot K. Chartash, William T. Barchuk, Susan K. Paulson, Kenneth B. Gordon, Walid M. Awni, Yanjun Bao, William G. Glass, Yihua Gu, Thomas C. Harris, Martin Kaul, Parvez M. Mulani, Peter A. Noertersheuser, Martin M. Okun
  • Methods for treating psoriasis using antibodies that bind to the P40 subunit of IL-12 and/or IL-23
    Patent number: 8557239
    Abstract: The invention provides methods of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Grant
    Filed: September 14, 2010
    Date of Patent: October 15, 2013
    Assignees: AbbVie Inc., AbbVie Deutschland GmbH & Co. KG
    Inventors: Joaquin Mario Valdes, Elliot K. Chartash, William T. Barchuk, Susan K. Paulson, Kenneth B. Gordon, Walid M. Awni, Yanjun Bao, William G. Glass, Yihua Gu, Tom C. Harris, Martin Kaul, Parvez M. Mulani, Peter Noertersheuser, Martin M. Okun
  • TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS (JRA)
    Publication number: 20130243786
    Abstract: Methods of treating TNF?-related disorders comprising administering TNF? inhibitors, including TNF? antibodies are described.
    Type: Application
    Filed: July 18, 2003
    Publication date: September 19, 2013
    Applicant: Abbott Biotechnology Ltd.
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey, Elliot K. Chartash, Rebecca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven Fischkoff
  • Multiple-variable dose regimen for treating TNFa-related disorders
    Publication number: 20130122011
    Abstract: Multiple-variable dose methods for treating TNF?-related disorders, including Crohn's disease and psoriasis, comprising administering TNF? inhibitors, including TNF? antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF-inhibitor is administered in a higher dosage during the induction phase.
    Type: Application
    Filed: March 28, 2012
    Publication date: May 16, 2013
    Inventors: Rebecca S. Hoffman, Elliot K. Chartash, Lori K. Taylor, George R. Granneman, Philip Yan, Susan K. Paulson, Joanna Z. Peng
  • METHODS FOR TREATING PSORIASIS
    Publication number: 20120189637
    Abstract: The invention provides methods of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: October 6, 2011
    Publication date: July 26, 2012
    Inventors: Joaquin Mario Valdes, Susan K. Paulson, Elliot K. Chartash, Yanjun Bao, Parvez M . Mulani, Murali Sundaram, Yihua Gu, Michele Olds Heckaman, Tom C. Harris, Martin Kaul, David Allen Williams, Richard G.B. Langley, Kenneth Gordon
  • METHODS FOR TREATING PSORIASIS
    Publication number: 20110206680
    Abstract: The invention provides methods of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: September 14, 2010
    Publication date: August 25, 2011
    Applicants: ABBOTT LABORATORIES, ABBOTT GMBH & CO., KG
    Inventors: JOAQUIN MARIO VALDES, ELLIOT K. CHARTASH, WILLIAM T. BARCHUK, SUSAN K. PAULSON, KENNETH B. GORDON, WALID M. AWNI, YANJUN BAO, WILLIAM G. GLASS, YIHUA GU, TOM C. HARRIS, MARTIN KAUL, PARVEZ M. MULANI, PETER NOERTERSHEUSER, MARTIN M. OKUM
  • METHODS FOR TREATING PSORIASIS
    Publication number: 20100297143
    Abstract: The invention provides a method of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: June 10, 2010
    Publication date: November 25, 2010
    Applicant: Abbott Laboratories
    Inventors: Elliot K. Chartash, William T. Barchuk, Susan K. Paulson, Joaquin M. Valdes, Alexandra B. Kimball
  • Methods of treating plaque psoriasis
    Patent number: 7776331
    Abstract: The invention provides a method of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Grant
    Filed: January 16, 2008
    Date of Patent: August 17, 2010
    Assignee: Abbott Laboratories
    Inventors: Elliot K. Chartash, William T. Barchuk, Susan K. Paulson, Joaquin M. Valdes, Alexandra B. Kimball
  • Multiple-variable dose regimen for treating TNFa-related disorders
    Publication number: 20090304682
    Abstract: Multiple-variable dose methods for treating TNF?-related disorders, including Crohn's disease and psoriasis, comprising administering TNF? inhibitors, including TNF? antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF-inhibitor is administered in a higher dosage during the induction phase.
    Type: Application
    Filed: January 7, 2008
    Publication date: December 10, 2009
    Inventors: Rebecca S. Hoffman, Elliot K. Chartash, Lori K. Taylor, George R. Granneman, Philip Yan, Susan K. Paulson, Joanna Z. Peng
  • Treatment of Anemia Using TNFalpha Inhibitors
    Publication number: 20080193466
    Abstract: Methods for treating anemia in which TNF? activity is detrimental are described.
    Type: Application
    Filed: April 14, 2008
    Publication date: August 14, 2008
    Applicant: ABBOTT BIOTECHNOLOGY LTD.
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey, Elliot K. Chartash, Rebacca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven Fischkoff
  • Treatment of skin and nail disorders using TNFalpha inhibitors
    Publication number: 20040219142
    Abstract: Methods of treating TNF&agr;-related skin and nail disorders are described.
    Type: Application
    Filed: July 18, 2003
    Publication date: November 4, 2004
    Applicants: Abbott Laboratories S.A., Abbott Biotechnology Ltd.
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey, Elliot K. Chartash, Rebecca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven Fischkoff
  • Treatment of metabolic disorders using TNFalpha inhibitors
    Publication number: 20040151722
    Abstract: Methods for treating metabolic disorders, including diabetes and obesity, using TNF&agr; inhibitors are described.
    Type: Application
    Filed: July 18, 2003
    Publication date: August 5, 2004
    Applicant: Abbott Biotechnology Ltd.
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey, Elliot K. Chartash, Rebecca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven Fischkoff
  • Treatment of pain using TNFalpha inhibitors
    Publication number: 20040136990
    Abstract: Methods for treating pain syndromes in which TNF&agr; activity is detrimental are described.
    Type: Application
    Filed: July 18, 2003
    Publication date: July 15, 2004
    Applicant: Abbott Biotechnology Ltd.
    Inventors: Subhashis Banerjee, Lori K. Taylor, Clive E. Spiegler, Daniel Edward Tracey, Elliot K. Chartash, Rebecca S. Hoffman, William T. Barchuk, Philip Yan, Anwar Murtaza, Jochen G. Salfeld, Steven Fischkoff